Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma von Eatrides, Jennifer, Wang, Emilie, Kothari, Nishi, Kim, Richard

Volltext

Epidermal growth factor receptor inhibitors: coming of age von Mahipal, Amit, Kothari, Nishi, Gupta, Shilpa

Volltext

Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing von Kothari, Nishi, Schell, Michael J, Teer, Jamie K, Yeatman, Timothy, Shibata, David, Kim, Richard

Volltext

S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B‐CELL MALIGNANCIES von Dickinson, Michael, Hamad, Nada, Bryant, Christian, Kothari, Nishi, Ojeras, Paulius, Vohra, Anmol, Lin, Ming, Tohme, Mira, Trager, James, Shook, David, Kennedy, Glen, Tees, Michael, Hill, Brian T.

Volltext

Current status of novel agents in advanced gastroesophageal adenocarcinoma von Kothari, Nishi, Almhanna, Khaldoun

Volltext

A Phase 1 Study of NKX101, a Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Therapy, with Fludarabine and Cytarabine in Patients with Acute Myeloid Leukemia von Sauter, Craig S, Borthakur, Gautam, Mountjoy, Luke, Rotta, Marcello, Liu, Hongtao, Murthy, Hemant S., Lin, Ming, Trager, James, Chang, Cornell, Kothari, Nishi, Shook, David, Bachier, Carlos

Volltext

Multidisciplinary Management of Rectal Cancer with Synchronous Resectable Liver Metastases von Kothari, Nishi, Anaya, Daniel A.

Volltext

Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers von Kothari, Nishi, Teer, Jamie K., Abbott, Andrea M., Srikumar, Thejal, Zhang, Yonghong, Yoder, Sean J., Brohl, Andrew S., Kim, Richard D., Reed, Damon R., Shibata, David

Volltext

EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience von Kim, Dae Won, Byer, Jennifer, Kothari, Nishi, Mahipal, Amit, Chang, Yound Doo, Kim, Richard D.

Volltext

A phase III randomized, placebo-controlled, double-blind study of niraparib plus abiraterone acetate and prednisone versus abiraterone acetate and prednisone in patients with metas... von Chi, Kim N., Rathkopf, Dana E., Attard, Gerhardt, Smith, Matthew Raymond, Efstathiou, Eleni, Olmos, David, Small, Eric Jay, Lee, Ji Youl, Ricci, Deborah S., Simon, Jason S., Zhao, Xin, Kothari, Nishi, Cheng, Shinta, Sandhu, Shahneen Kaur

Volltext

A phase III randomized, placebo-controlled, double-blind study of niraparib plus abiraterone acetate and prednisone versus abiraterone acetate and prednisone in patients with metas... von Chi, Kim N., Rathkopf, Dana E., Attard, Gerhardt, Smith, Matthew Raymond, Efstathiou, Eleni, Olmos, David, Small, Eric Jay, Lee, Ji Youl, Sieber, Paul R., Dunshee, Curtis, Ricci, Deborah S., Simon, Jason S., Zhao, Xin, Kothari, Nishi, Cheng, Shinta, Sandhu, Shahneen Kaur

Volltext

A phase Ia/Ib trial of trametinib in combination with sorafenib in patients with advanced hepatocellular cancer von Soares, Heloisa P., Kim, Richard D., Kothari, Nishi, Cooksey, Jennifer, Springett, Gregory M., Mahipal, Amit

Volltext

A single institution experience of EGFR inhibitors in patients with advanced squamous cell anal carcinomas (SCAC) von Kim, Dae Won, Byer, Jennifer Elizabeth, Kothari, Nishi, Mahipal, Amit, Kim, Richard D.

Volltext

An investigator sponsored phase Ia/Ib trial of selinexor in combination with irinotecan in patients with adenocarcinoma of stomach and distal esophagus von Soares, Heloisa P., Kim, Richard D., Almhanna, Khaldoun, Willians-Elson, Irene, Kothari, Nishi, Mahipal, Amit

Volltext

PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer von Kim, Richard, Prithviraj, Gopi, Kothari, Nishi, Springett, Greg, Malafa, Mokenge, Hodul, Pamela, Kim, Jongphil, Yue, Binglin, Morse, Brian, Mahipal, Amit

Volltext

A phase Ib/II study of niraparib combination therapies for the treatment of metastatic castration-resistant prostate cancer (NCT03431350) von Subudhi, Sumit Kumar, Aparicio, Ana, Zurita, Amado J., Doger, Bernard, Kelly, William Kevin, Peer, Avivit, Rathkopf, Dana E., Karsh, Lawrence Ivan, Tryon, Jeffrey J., Kothari, Nishi, Zhao, Xin, Zhu, Eugene, Ricci, Deborah S., Tran, Namphuong, De Bono, Johann S.

Volltext

Prognostic and predictive values of APC and WNT pathway mutations in MSS colorectal cancers von Kothari, Nishi, Yue, Binglin, Teer, Jamie K., Schell, Michael J., Kim, Richard D.

Volltext

A phase I trial with cohort expansion of BYL719 in combination with gemcitabine and nab-paclitaxel in locally advanced and metastatic pancreatic cancer von Soares, Heloisa P., Nguyen, Danny, Springett, Gregory M., Kim, Richard D., Williams-Elson, Irene, Miller, Kara, Kothari, Nishi, Mahipal, Amit

Volltext

Adjuvant chemotherapy and outcomes in esophageal carcinoma von Saeed, Nadia, Mellon, Eric Albert, Meredith, Kenneth L, Hoffe, Sarah E., Shridhar, Ravi, Frakes, Jessica M., Fontaine, Jacques-Pierre, Pimiento, Jose Mario, Kothari, Nishi, Almhanna, Khaldoun

Volltext

781 DELTA-2: A phase 1, open-label, multicenter study of ITIL-168, an autologous tumor-infiltrating lymphocyte (TIL) cell therapy, with pembrolizumab in patients with advanced soli... von Yeku, Oladapo, Olson, Daniel, Ward, Jeffrey, Patel, Sandip, Aycock, Jeff, Donahue, Amber, Jiang, Yizhou, John Le Gall, Roberts, Zachary, Alvarez-Rodríguez, Rubén, Seng, Judy, Shen, Tong, Kothari, Nishi

Volltext